Health Care & Life Sciences » Pharmaceuticals | Daiichi Sankyo Co. Ltd.

Daiichi Sankyo Co. Ltd.

Daiichi Sankyo Co. Ltd. ADR
Stock Exchange Other OTC
EPS
$1.29
Market Cap
$35.92 B
Shares Outstanding
709.01 M
Public Float
-
Daiichi Sankyo Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY143.87
Market Cap
JPY3.9 T
Shares Outstanding
709.01 M
Public Float
507.46 M

Profile

Address
Daiichi Sankyo Head Office Bldg, A&B
Tokyo Tokyo 103
Japan
Employees -
Website http://www.daiichisankyo.co.jp
Updated 07/08/2019
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries.

Financials

View All
Created with Highcharts 5.0.14Daiichi Sankyo Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Millions.60 94360 94346 76246 76282 28282 28253 46653 46660 28260 28293 41093 410201420152016201720182019025k50k75k100k
Created with Highcharts 5.0.14Daiichi Sankyo Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.1 118 2411 118 241919 372919 372986 446986 446955 124955 124960 195960 195929 717929 7172014201520162017201820190250k500k750k1 000k1 250k

Joji Nakayama
Chairman & CEO
Sunao Manabe
President, COO & Representative Director